Figure 4.

Flow-chart for systemic therapy of metastatic disease (1, 4, 22); black letters: potentially interesting therapy for cluster 1; gray letters: potentially interesting therapy for cluster 2. Abbreviations: SSA, somatostatin analogues; TKI, tyrosine kinase inhibitor.